Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Current Leases (2017 - 2025)

Bioceres Crop Solutions' Current Leases history spans 9 years, with the latest figure at $6.9 million for Q2 2025.

  • On a quarterly basis, Current Leases rose 120.45% to $6.9 million in Q2 2025 year-over-year; TTM through Jun 2025 was $6.9 million, a 120.45% increase, with the full-year FY2025 number at $6.9 million, up 120.45% from a year prior.
  • Current Leases hit $6.9 million in Q2 2025 for Bioceres Crop Solutions, up from $3.1 million in the prior quarter.
  • Over the last five years, Current Leases for BIOX hit a ceiling of $6.9 million in Q2 2025 and a floor of $750308.0 in Q2 2021.
  • Historically, Current Leases has averaged $2.9 million across 5 years, with a median of $2.3 million in 2022.
  • Biggest five-year swings in Current Leases: skyrocketed 173.1% in 2023 and later decreased 19.07% in 2024.
  • Tracing BIOX's Current Leases over 5 years: stood at $1.4 million in 2021, then grew by 2.31% to $1.4 million in 2022, then skyrocketed by 173.1% to $3.9 million in 2023, then decreased by 19.07% to $3.1 million in 2024, then skyrocketed by 120.45% to $6.9 million in 2025.
  • Business Quant data shows Current Leases for BIOX at $6.9 million in Q2 2025, $3.1 million in Q2 2024, and $3.9 million in Q2 2023.